Kerwash, E.; Sajic, M.; Rantell, K.R.; McBlane, J.W.; Johnston, J.D.; Niewiarowska, A.; Butler, A.S.; Cole, S.
Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises. Curr. Issues Mol. Biol. 2024, 46, 8209-8225.
https://doi.org/10.3390/cimb46080485
AMA Style
Kerwash E, Sajic M, Rantell KR, McBlane JW, Johnston JD, Niewiarowska A, Butler AS, Cole S.
Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises. Current Issues in Molecular Biology. 2024; 46(8):8209-8225.
https://doi.org/10.3390/cimb46080485
Chicago/Turabian Style
Kerwash, Essam, Marija Sajic, Khadija Rerhou Rantell, James W. McBlane, John D. Johnston, Alison Niewiarowska, Andrew S. Butler, and Susan Cole.
2024. "Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises" Current Issues in Molecular Biology 46, no. 8: 8209-8225.
https://doi.org/10.3390/cimb46080485
APA Style
Kerwash, E., Sajic, M., Rantell, K. R., McBlane, J. W., Johnston, J. D., Niewiarowska, A., Butler, A. S., & Cole, S.
(2024). Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises. Current Issues in Molecular Biology, 46(8), 8209-8225.
https://doi.org/10.3390/cimb46080485
